Atlas Trials

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Clinical trial NCT01958970 · COMPLETED

Trial details

NCT number
NCT01958970
Sponsor
Pinta Biotherapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
End Stage Renal DiseaseKidney DiseaseProtein Energy Wasting
Start date
2014-01-01
Primary completion
2015-11-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.